• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

2000年至2017年加拿大囊性纤维化患者感染的流行病学

Epidemiology of Infections in People with Cystic Fibrosis in Canada between 2000 and 2017.

作者信息

Zlosnik James E A, Henry Deborah A, Hird Trevor J, Hickman Rebecca, Campbell Maureen, Cabrera Adriana, Laino Chiavegatti Giulio, Chilvers Mark A, Sadarangani Manish

机构信息

Division of Infectious Diseases, Department of Pediatrics, Faculty of Medicine.

Healthy Starts Theme, and.

出版信息

Ann Am Thorac Soc. 2020 Dec;17(12):1549-1557. doi: 10.1513/AnnalsATS.201906-443OC.

DOI:10.1513/AnnalsATS.201906-443OC
PMID:32946281
Abstract

Infections by species bacteria in cystic fibrosis (CF) may be transmissible, necessitating infection control measures, and remain a serious cause of morbidity and mortality. The last major study of epidemiology in Canada included cases up until July 2000 and was marked by the dominance of a limited number of epidemic clones of . Describe the nationwide epidemiology of species infections in people with cystic fibrosis in Canada over the 17-year period since 2000. Isolates were collected from across Canada between August 2000 and July 2017 and identified to the species and, for isolates between 2015 and 2017, strain level. We analyzed 1,362 isolates from at least 396 people with CF. Forty-nine percent ( = 666) of all isolates and 47% ( = 179) of new incident infections were identified as . The incidence of infection in the Canadian CF population did not change between 2000 and 2017 at 6 cases per 1,000 annually. Multilocus sequence typing analysis suggested minimal sharing of clones in Canada. The epidemiology of in CF in Canada has shifted from limited numbers of epidemic strains of to largely nonclonal isolates of , , and other species. Despite widespread infection control, however, species bacteria continue to be acquired by people with CF at an unchanged rate, posing a continued hazard.

摘要

囊性纤维化(CF)患者感染某些细菌可能具有传染性,因此需要采取感染控制措施,而且这些感染仍是发病和死亡的严重原因。加拿大上一次关于该疾病流行病学的主要研究涵盖截至2000年7月的病例,其特点是少数几种流行克隆菌株占主导地位。描述2000年以来17年间加拿大囊性纤维化患者中某些细菌感染的全国性流行病学情况。在2000年8月至2017年7月期间从加拿大各地收集分离株,并鉴定到种水平,对于2015年至2017年的分离株,鉴定到菌株水平。我们分析了至少396名囊性纤维化患者的1362株分离株。所有分离株的49%(n = 666)和新发病例感染的47%(n = 179)被鉴定为[具体细菌名称未给出]。2000年至2017年期间,加拿大囊性纤维化人群中[具体细菌名称未给出]感染的发病率保持在每年每1000人6例不变。多位点序列分型分析表明加拿大的克隆菌株共享极少。加拿大囊性纤维化患者中[具体细菌名称未给出]的流行病学已从少数几种流行菌株转变为主要是[具体细菌名称未给出]、[具体细菌名称未给出]和其他菌种的非克隆分离株。然而,尽管广泛采取了感染控制措施,囊性纤维化患者感染某些细菌的比例仍未改变,持续构成威胁。

相似文献

1
Epidemiology of Infections in People with Cystic Fibrosis in Canada between 2000 and 2017.2000年至2017年加拿大囊性纤维化患者感染的流行病学
Ann Am Thorac Soc. 2020 Dec;17(12):1549-1557. doi: 10.1513/AnnalsATS.201906-443OC.
2
Burkholderia species infections in patients with cystic fibrosis in British Columbia, Canada. 30 years' experience.加拿大不列颠哥伦比亚省囊性纤维化患者的伯克霍尔德菌属感染。30年经验。
Ann Am Thorac Soc. 2015 Jan;12(1):70-8. doi: 10.1513/AnnalsATS.201408-395OC.
3
Epidemiology of Burkholderia cepacia complex species recovered from cystic fibrosis patients: issues related to patient segregation.从囊性纤维化患者中分离出的洋葱伯克霍尔德菌复合体菌种的流行病学:与患者隔离相关的问题。
J Med Microbiol. 2004 Jul;53(Pt 7):663-668. doi: 10.1099/jmm.0.45557-0.
4
Burkholderia cenocepacia in cystic fibrosis: epidemiology and molecular mechanisms of virulence.西地西菌属在囊性纤维化中的作用:流行病学和毒力的分子机制。
Clin Microbiol Infect. 2010 Jul;16(7):821-30. doi: 10.1111/j.1469-0691.2010.03237.x.
5
Elucidating global epidemiology of Burkholderia multivorans in cases of cystic fibrosis by multilocus sequence typing.通过多位点序列分型阐明多噬伯克霍尔德菌在囊性纤维化病例中的全球流行病学。
J Clin Microbiol. 2008 Jan;46(1):290-5. doi: 10.1128/JCM.01818-07. Epub 2007 Nov 21.
6
Prevalence of Burkholderia species, including members of Burkholderia cepacia complex, among UK cystic and non-cystic fibrosis patients.英国囊性纤维化和非囊性纤维化患者中伯克霍尔德菌属(包括洋葱伯克霍尔德菌复合体成员)的患病率。
J Med Microbiol. 2017 Apr;66(4):490-501. doi: 10.1099/jmm.0.000458.
7
Epidemiology and clinical course of Burkholderia cepacia complex infections, particularly those caused by different Burkholderia cenocepacia strains, among patients attending an Italian Cystic Fibrosis Center.意大利一家囊性纤维化中心的患者中洋葱伯克霍尔德菌复合体感染的流行病学及临床病程,特别是由不同洋葱伯克霍尔德菌菌株引起的感染。
J Clin Microbiol. 2004 Apr;42(4):1491-7. doi: 10.1128/JCM.42.4.1491-1497.2004.
8
Epidemiology of Burkholderia cepacia complex in patients with cystic fibrosis, Canada.加拿大囊性纤维化患者中洋葱伯克霍尔德菌复合体的流行病学
Emerg Infect Dis. 2002 Feb;8(2):181-7. doi: 10.3201/eid0802.010163.
9
Epidemiology of Burkholderia cepacia complex colonisation in cystic fibrosis patients.囊性纤维化患者中洋葱伯克霍尔德菌复合体定植的流行病学
Eur Respir J. 2004 Jun;23(6):851-6. doi: 10.1183/09031936.04.00118804.
10
Increase in isolation of Burkholderia contaminans from Spanish patients with cystic fibrosis.从西班牙囊性纤维化患者中分离出越来越多的污染伯克霍尔德菌。
Clin Microbiol Infect. 2015 Feb;21(2):150-6. doi: 10.1016/j.cmi.2014.07.014. Epub 2014 Oct 12.

引用本文的文献

1
Mutation of , encoding homogentisate 1,2-dioxygenase, is responsible for pyomelanin production but does not impact the virulence of in a chronic granulomatous disease mouse lung infection.编码 1,2-二羟苯并[g,h]喹啉-1,4-二氧加双氧酶的基因突变可导致焦黑素的产生,但并不影响 在慢性肉芽肿病小鼠肺部感染中的毒力。
Microbiol Spectr. 2024 Jul 2;12(7):e0041024. doi: 10.1128/spectrum.00410-24. Epub 2024 May 29.
2
Non-coding regulatory sRNAs from bacteria of the Burkholderia cepacia complex.伯克霍尔德氏菌复合群中细菌的非编码调控 sRNAs。
Appl Microbiol Biotechnol. 2024 Apr 2;108(1):280. doi: 10.1007/s00253-024-13121-6.
3
Complex Subunit and Glycoconjugate Vaccines and Their Potential to Elicit Cross-Protection to Complex.
复合亚单位疫苗和糖缀合物疫苗及其引发对复合物交叉保护的潜力。
Vaccines (Basel). 2024 Mar 15;12(3):313. doi: 10.3390/vaccines12030313.
4
Showing the limitations of available phenotypic assays to detect from clinical specimens in Nigeria.显示了尼日利亚现有表型检测方法在从临床标本中进行检测方面的局限性。
Access Microbiol. 2023 Oct 18;5(10). doi: 10.1099/acmi.0.000604.v5. eCollection 2023.
5
Preclinical testing of antimicrobials for cystic fibrosis lung infections: current needs and future priorities.抗微生物药物治疗囊性纤维化肺部感染的临床前试验:当前需求和未来重点。
Microbiology (Reading). 2023 Jul;169(7). doi: 10.1099/mic.0.001361.
6
Phenotype-Guided Comparative Genomics Identifies the Complete Transport Pathway of the Antimicrobial Lasso Peptide Ubonodin in .表型导向的比较基因组学鉴定抗菌拉索肽 Ubonodin 的完整转运途径
ACS Chem Biol. 2022 Aug 19;17(8):2332-2343. doi: 10.1021/acschembio.2c00420. Epub 2022 Jul 8.
7
Thinking Outside the Bug: Targeting Outer Membrane Proteins for Vaccines.跳出固有思维:针对外膜蛋白的疫苗策略。
Cells. 2021 Feb 25;10(3):495. doi: 10.3390/cells10030495.